(1R,2R,9R,17S)-7,13-Diazatetracyclo[7.7.1.02,7.013,17]heptadec-4-en-6-one

Details

Top
Internal ID 7bbd3c5a-969a-47d1-a026-3447e9717d14
Taxonomy Alkaloids and derivatives > Lupin alkaloids > Matrine alkaloids
IUPAC Name (1R,2R,9R,17S)-7,13-diazatetracyclo[7.7.1.02,7.013,17]heptadec-4-en-6-one
SMILES (Canonical) C1CC2CN3C(CC=CC3=O)C4C2N(C1)CCC4
SMILES (Isomeric) C1C[C@@H]2CN3[C@H](CC=CC3=O)[C@@H]4[C@H]2N(C1)CCC4
InChI InChI=1S/C15H22N2O/c18-14-7-1-6-13-12-5-3-9-16-8-2-4-11(15(12)16)10-17(13)14/h1,7,11-13,15H,2-6,8-10H2/t11-,12-,13-,15+/m1/s1
InChI Key AAGFPTSOPGCENQ-BHPKHCPMSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22N2O
Molecular Weight 246.35 g/mol
Exact Mass 246.173213330 g/mol
Topological Polar Surface Area (TPSA) 23.60 Ų
XlogP 1.70
Atomic LogP (AlogP) 1.65
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
(1R,2R,9R,17S)-7,13-Diazatetracyclo[7.7.1.02,7.013,17]heptadec-4-en-6-one

2D Structure

Top
2D Structure of (1R,2R,9R,17S)-7,13-Diazatetracyclo[7.7.1.02,7.013,17]heptadec-4-en-6-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9885 98.85%
Caco-2 + 0.9200 92.00%
Blood Brain Barrier + 0.9750 97.50%
Human oral bioavailability + 0.6714 67.14%
Subcellular localzation Mitochondria 0.5101 51.01%
OATP2B1 inhibitior - 0.8585 85.85%
OATP1B1 inhibitior + 0.9421 94.21%
OATP1B3 inhibitior + 0.9518 95.18%
MATE1 inhibitior - 0.9209 92.09%
OCT2 inhibitior + 0.8250 82.50%
BSEP inhibitior - 0.7512 75.12%
P-glycoprotein inhibitior - 0.9482 94.82%
P-glycoprotein substrate - 0.7438 74.38%
CYP3A4 substrate + 0.5118 51.18%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7702 77.02%
CYP3A4 inhibition - 0.9310 93.10%
CYP2C9 inhibition - 0.9005 90.05%
CYP2C19 inhibition - 0.7025 70.25%
CYP2D6 inhibition - 0.9136 91.36%
CYP1A2 inhibition - 0.7062 70.62%
CYP2C8 inhibition - 0.9514 95.14%
CYP inhibitory promiscuity - 0.6415 64.15%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.6175 61.75%
Eye corrosion - 0.9027 90.27%
Eye irritation - 0.7012 70.12%
Skin irritation - 0.6244 62.44%
Skin corrosion - 0.8953 89.53%
Ames mutagenesis - 0.8000 80.00%
Human Ether-a-go-go-Related Gene inhibition + 0.6629 66.29%
Micronuclear - 0.5700 57.00%
Hepatotoxicity + 0.7625 76.25%
skin sensitisation - 0.8751 87.51%
Respiratory toxicity + 0.7778 77.78%
Reproductive toxicity + 0.7222 72.22%
Mitochondrial toxicity + 0.8500 85.00%
Nephrotoxicity + 0.6956 69.56%
Acute Oral Toxicity (c) II 0.7391 73.91%
Estrogen receptor binding - 0.8079 80.79%
Androgen receptor binding - 0.5385 53.85%
Thyroid receptor binding - 0.6787 67.87%
Glucocorticoid receptor binding - 0.6222 62.22%
Aromatase binding - 0.8303 83.03%
PPAR gamma - 0.6799 67.99%
Honey bee toxicity - 0.8822 88.22%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity + 0.6800 68.00%
Fish aquatic toxicity - 0.7681 76.81%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 90.68% 98.95%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 89.87% 93.40%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.19% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.12% 97.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.71% 95.56%
CHEMBL3384 Q16512 Protein kinase N1 86.16% 80.71%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.79% 95.89%
CHEMBL2781 P19634 Sodium/hydrogen exchanger 1 83.94% 90.24%
CHEMBL253 P34972 Cannabinoid CB2 receptor 83.77% 97.25%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 82.41% 93.04%
CHEMBL1907600 Q00535 Cyclin-dependent kinase 5/CDK5 activator 1 81.80% 93.03%
CHEMBL1994 P08235 Mineralocorticoid receptor 80.67% 100.00%
CHEMBL264 Q9Y5N1 Histamine H3 receptor 80.10% 91.43%

Cross-Links

Top
PubChem 21763818
NPASS NPC120699
LOTUS LTS0195595
wikiData Q104907902